Pipeline
working towards a new first-in-class IND
GABAeron is working to deliver a new first-in-class IND candidate to replace or restore neurons injured or lost in the brains of patients suffering from neurodegenerative and neurodevelopmental disorders.
Pipeline Targeting CNS Therapeutics
for Neurodegenerative Disorders
Careers at GABAeron
We are looking for colleagues who are team players, always learning, dedicated to conducting rigorous science, and passionate about improving the lives of patients with neurodegenerative and neurodevelopmental disorders. GABAeron has positions open for those looking to join a focused organization with opportunities to guide early lab discoveries towards meaningful disease-modifying therapeutics.